News and Announcements
YPB Secures 14 million Unit Reorder for VariSec Passport Solution
- Published May 03, 2016 4:09PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd May 2016, ASX Announcement
Highlights:
- Reorder of YPB’s VariSec technology for a major first world economy
- Total gross revenue approximately A$500,00
- YPB’s Government Vital Documents business rapid growth continues
YPB Group Ltd (ASX:YPB) is pleased to announce that it has received a further order for its proprietary VariSec technology to apply to approximately 14 million ePassports in a deal that is expected to generate A$500,000 gross revenue.
The reorder of the technology is for a major first world economy which previously ordered VariSec technology in October 2015. It is estimated that these new passports will be issued in the next six months.
The reorder of VariSec from the major first world western economy highlights the reoccurring nature of the market for securing passports. YPB expects the country to place a third order for the technology in the latter months of 2016.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
